“Moderna, whose CEO Stephane Bancel told CNBC last week that the biotech firm hopes to be “ready commercially” to make a vaccine widely available in the U.S. in 2021.“

Analyst call 54.19 short term then upon breaking - sailing to 59.61 best part, next week!
 #SP500